BridgeBio Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	570.12	681.1	392.59	414.62	393.95
Short-Term Investments	17.36	-	58.95	95.23	442.89
Cash & Short-Term Investments	587.48	681.1	451.54	509.85	836.84
Cash Growth	-13.74%	50.84%	-11.44%	-39.07%	37.84%
Accounts Receivable	139.44	4.72	1.75	-	-
Other Receivables	-	-	-	17.08	19.75
Total Trade Receivables	139.44	4.72	1.75	17.08	19.75
Inventory	26.75	-	-	-	-
Other Current Assets	44.07	34.87	24.31	21.92	32.27
Total Current Assets	797.75	720.69	477.59	548.85	888.86
Net Property, Plant & Equipment	13.52	12.78	19.84	25.25	45.97
Other Intangible Assets	28.08	23.93	26.32	28.71	44.93
Long-Term Investments	79.97	143.75	-	-	-
Other Long-Term Assets	16.71	18.2	22.63	20.22	33.03
Total Assets	936.03	919.34	546.38	623.04	1,013
Accounts Payable	36.23	9.62	10.66	11.56	11.88
Accrued Expenses	118.14	92.6	87.14	71.06	81.18
Current Portion of Leases	6.19	4.51	4.13	3.68	4.94
Unearned Revenue	7.19	14.6	6.1	8.16	-
Other Current Liabilities	120.22	33.07	35.83	26.98	37.07
Total Current Liabilities	287.97	154.4	143.84	121.43	135.07
Long-Term Debt	1,852	1,721	1,727	1,708	1,704
Long-Term Leases	3.81	4.7	8.98	12.27	17.43
Other Long-Term Liabilities	868.35	496.47	9.36	26.64	22.07
Total Long-Term Liabilities	2,725	2,223	1,745	1,747	1,743
Total Liabilities	3,013	2,377	1,889	1,868	1,878
Common Stock	0.2	0.2	0.18	0.16	0.15
Treasury Stock	-323.28	-275	-275	-275	-275
Additional Paid-in Capital	2,058	1,903	1,481	938.7	841.53
Accumulated Other Comprehensive Income	0.01	0.01	0.03	-0.33	-0.13
Retained Earnings	-3,821	-3,096	-2,561	-1,918	-1,437
Total Common Shareholders' Equity	-2,087	-1,468	-1,354	-1,255	-870.41
Minority Interest	10.03	10.29	11.72	9.69	4.84
Shareholders' Equity	-2,077	-1,458	-1,343	-1,245	-865.58
Total Liabilities & Equity	936.03	919.34	546.38	623.04	1,013
Total Debt	1,862	1,731	1,740	1,724	1,726
Net Cash (Debt)	-1,275	-1,049	-1,288	-1,214	-889.33
Net Cash Per Share	-6.66	-5.64	-7.91	-8.23	-6.16
Book Value	-2,087	-1,468	-1,354	-1,255	-870.41
Book Value Per Share	-10.89	-7.89	-8.32	-8.51	-6.03
Tangible Book Value	-2,115	-1,492	-1,381	-1,283	-915.35
Tangible Book Value Per Share	-11.04	-8.02	-8.48	-8.70	-6.34

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q